Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Frederique M. Penault-Llorca
Based on 100 articles published since 2008
||||
Expertise Level
The expertise of Frederique M. Penault-Llorca ranks in the
  • Top 0.045%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 100 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Penault-Llorca, Fréderique   ·   Penault-Llorca, F   ·   Penault-Llorca, Frederique M   ·   Penault-Llorca, Frederique   ·   Pénault-Llorca, Frédérique   ·   Penault-Llorca, Frédérique M   ·   Penault Llorca, F   ·   Penault Llorca, Frédérique   ·   Penault-Llorca, Frédérique
Work Locations
Details
Most likely:    Universite Clermont Auvergne      
2018
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, University Clermont Auvergne, 58 rue Montalembert-BP184, 63005 Clermont-Ferrand, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 30324811
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · Master Program « Biology & Health », University Paris-East Val-de-Marne (UPEC), 61 avenue du General de Gaulle, 94010, Creteil, France. · Present Address: Department of Pathology, Paoli-Calmettes Comprehensive Cancer Centre, 232 boulevard Sainte-Marguerite, 13009, Marseilles, France. · Department of Clinical Research, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 29394917
2017
  • Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address: · Centre Jean-Perrin, département de chirurgie oncologique, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France; Université d'Auvergne, faculté de médecine, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France. · Pubmed 27986267
  • Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. · Department of Pharmacogenomics, Institut Curie, Paris, France. · Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · Department of Gynecology, Poissy-St Germain hospital, Poissy, France. · Department of Gynecology, Tenon Hospital, Paris, France. · Department of Gynecology, René Dubos Hospital, Pontoise, France. · Department of Medical Oncology, Private Hospital Clairval, Marseille, France. · Department of Surgery, Private Hospital Les Peupliers, Paris, France. · Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. · NanoString Technologies, Inc., Seattle, WA, United States of America. · Cedar Associates LLC, Menlo Park, CA, United States of America. · Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. · Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. · Pubmed 29045452
  • Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand, France. · Université d'Auvergne, ERTICa-EA4677, Faculté de Médecine, 28 place Henri Dunant, Clermont-Ferrand, France. · Adelbio, 13 Rue du Pariou, Aubière, France. · Pubmed 28430808
  • Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France. · LabEx DEVweCAN, Université de Lyon, Lyon, France. · Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France. · Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France. · Centre Léon Bérard, Lyon, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · ProfileXpert, Bron, France. · Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Clinique Phenicia, Marseille, France. · Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. · Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28394329
  • Departement of oncogenetics, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, University of Auvergne, Clermont-Ferrand, France. · Laboratory of Biochemistry Research unit UR 12ES08 Cell Signaling and Disease, Faculty of Medicine of Monastir, University of Monastir, 5019, Monastir, Tunisia. · Department of Pathology, Farhat Hached Hospital, 4000, Sousse, Tunisia. · Laboratory of Biochemistry Research unit UR 12ES08 Cell Signaling and Disease, Faculty of Medicine of Monastir, University of Monastir, 5019, Monastir, Tunisia. · Pubmed 28101798
  • Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France. · Pubmed 28065411
  • Centre Jean Perrin-ERTICa-EA4677, Clermont-Ferrand Cedex, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Faculté de Médecine, Clermont-Ferrand, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, Aubière cedex, France. · Centre de Ressources Biologiques BB-0033-00075, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 27864890
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France; EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France; EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France. Electronic address: · EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France; Department of Pathology, Centre Jean Perrin, 63011, Clermont-Ferrand, France. · Pubmed 26965997
  • Department of Pathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011 Clermont-Ferrand, France. · ERTICa Research Group, EA4677 University of Auvergne, 49 Boulevard Francois Mitterrand, 63000 Clermont-Ferrand, France. · Pubmed 26856744
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
  • Centre Jean Perrin - ERTICa-EA4677, BP392, 63011 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Faculté de Médecine, BP38, 63001 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble Universitaire des Cézeaux, BP86, 63172 Aubière Cedex, France. · Pubmed 27655662
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France. · EA 4677 'ERTICA', University of Auvergne, 63011 Clermont-Ferrand, France. · Department of Toxicology, Faculty of Pharmacy, Marmara University, 34668 Istanbul, Turkey. · University Blaise Pascal, Pascal Institute UMR 6602 CNRS/UBP, 63177 Aubière, France. · Department of Biopathology, Centre Jean Perrin, 63011 Clermont-Ferrand, France. · Pubmed 27424567
  • Synergie Lyon Cancer, Plateforme de bioinformatique 'Gilles Thomas' Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Institut Curie, PSL Research University, Département de Pathologie, INSERM U934, 26 rue d'Ulm, 75248 Paris, France. · Centre Hospitalier Universitaire de Minjoz, UMR INSERM 1098, Boulevard A. Fleming, Besançon 25000, France. · Plateforme de génomique des cancers, Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Institut Curie, UMR 3215 CNRS, Génétique et biologie du développement, Epigénèse et développement des mammifères, U934 Inserm, 26 rue d'Ulm, 75248 Paris, France. · Centre Léon Bérard, Département de Pathologie, 28 rue Laënnec, 69008 Lyon, France. · Département de Biopathologie, Unité Inserm U916, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France. · Centre Georges-François Leclerc et CRB Ferdinand Cabanne, 1 rue du Professeur Marion, Inserm U866-UBFC, 21000 Dijon, France. · Centre d'Etude du Polymorphisme Humain (CEPH), Fondation Jean Dausset, 27 rue Juliette Dodu, 75010 Paris, France. · Institut Paoli-Calmettes, Département de Pathologie, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Institut Gustave Roussy, Comité de Pathologie Mammaire, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Centre Jean Perrin, Département de Biopathologie, EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France. · Institut Régional du Cancer de Montpellier (ICM), Département de Pathologie, 208 Avenue des Apothicaires, 34298 Montpellier, France. · Institut Curie, PSL Research University, Service de Pathologie, Centre de Ressources Biologiques, BRIF BB-0033-00048, 26 rue d'Ulm, 75248 Paris, France. · Département de Pathologie, Institut Bergonié, 229 cours de l'Argonne, CS 61283, 33076 Bordeaux, France. · Institut Curie, PSL Research University, Département d'Oncologie Médicale, Université Paris Descartes, 26 rue d'Ulm, 75248 Paris, France. · Centre Léon Bérard, Département de Cancérologie Médicale, 28 rue Laënnec, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié Unicancer, University of Bordeaux, INSERM U916, CIC1401, 229 cours de l'Argonne, CS 61283, 33076 Bordeaux, France. · Institut Régional du Cancer de Montpellier (ICM), Oncologie Sénologie, 208 Avenue des Apothicaires, 34298 Montpellier, France. · Centre Alexis Vautrin, Département d'Oncologie Médicale, 6 Avenue de Bourgogne, 54511 Vandoeuvre Les Nancy, France. · Centre Antoine Lacassagne, Département d'Oncologie Médicale, 33 Avenue de Valombrose, 06189 Nice, France. · Institut Paoli-Calmettes, Département d'Oncologie Médicale, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Clinique Mutualiste de Bellevue, Chirurgie Gynécologique et Mammaire, 3 rue le Verrier, 42100 Saint-Etienne, France. · Institut Gustave Roussy, Cancer Core Europe, 39 rue Camille Desmoulins, Villejuif 94805, France. · CNAG-CRG, Centre for Genomic Regulation (CRG), C/Baldiri Reixac 4, 08028 Barcelona, Spain. · Universitat Pompeu Fabra, Plaça de la Mercè, 10, 08002 Barcelona, Spain. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Institut National du Cancer, Département de Recherche Clinique, 52 Avenue Morizet, 92513 Boulogne-Billancourt, France. · INSERM U1052-CNRS 5286, Cancer Research Center of Lyon, F-69008 Lyon, France. · Université de Lyon, F-69622 Lyon, France. · Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Département d'Oncologie Moléculaire, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Aix-Marseille Université, 232 boulevard de Sainte-Marguerite, 13009 Marseille, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655 Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Pubmed 27406316
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France. · University Blaise Pascal, Institute Pascal UMR 6602 CNRS/UBP, Aubière, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France Department of Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. · EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France · Pubmed 27365379
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • a Department of Medical Oncology , Georges François Leclerc Center , Dijon , France. · b Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy , Dijon , France. · c Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif , France. · d Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France. · f INSERM, U1138 , Paris , France. · g Université Paris Descartes, Sorbonne Paris Cité , Paris , France. · h University of Paris Sud XI , Villejuif , France. · i Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · j Center Jean Perrin, EA 4677 Clermont-Ferrand , Clermont-Ferrand , France. · k ERTICa, EA 4677 University of Auvergne , Clermont-Ferrand , France. · l Department of Pathology and Tumor Biology , Georges François Leclerc Center , Dijon , France. · m Biostatistics and Epidemiology Unit, EA 4184, Centre Georges Francois Leclerc Dijon , France. · n Department of Medical Oncology and Breast Cancer Group , Institut Gustave Roussy , Villejuif , France. · o INSERM U981 Identification of molecular predictors and new targets for cancer treatment , Institut Gustave Roussy , Villejuif , France. · p Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris , Paris , France. · q Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital , Stockholm , Sweden. · Pubmed 26979828
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France . · 2 EA 4677 "ERTICA, " University of Auvergne , Clermont-Ferrand, France . · 3 Department of Toxicology, Faculty of Pharmacy, Marmara University , Istanbul, Turkey . · 4 University Blaise Pascal , Pascal Institute UMR 6602 CNRS/UBP, Aubière, France . · 5 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France . · Pubmed 27326890
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France; CREAT EA 7283, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. Electronic address: · Pubmed 25900915
  • Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Europa Donna Cyprus, Nicosia, Cyprus. · Breast Oncology Center, Cancer Institute Hospital, Tokyo, Japan. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Diagnostic Radiology, Lund University, Malmö, Sweden. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Pubmed 26314782
  • a Department of Medical Oncology, Georges François Leclerc Center ; Dijon , France. · b Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy , Villejuif , France. · c Centre Jean Perrin, EA 4677 Clermont-Ferrand ; Clermont-Ferrand , France. · d ERTICa; EA 4677 University of Auvergne ; Clermont-Ferrand , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris , France. · f Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus ; Villejuif , France. · g Biostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon , France. · h Université Paris Descartes; Sorbonne Paris Cité ; Paris , France. · i Department of Pathology and Tumor Biology; Georges François Leclerc Center ; Dijon , France. · j Institut National de la Santé et de la Recherche Médicale; Avenir Team INSERM; CRI-866 University of Burgundy , Dijon , France. · k Department of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy , Villejuif , France. · l INSERM U981 "Identification of molecular predictors and new targets for cancer treatment"; Institut Gustave Roussy ; Villejuif , France. · m University of Paris Sud XI , Villejuif , France. · n Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · o Pôle de Biologie; Hôpital Européen Georges Pompidou; Assistance Publique-Hôpitaux de Paris ; Paris , France. · p INSERM; U1138 , Paris , France. · Pubmed 26506894
  • Département d'Oncogénétique, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, Université d'Auvergne, Clermont-Ferrand, France. · Faculté de médecine de Monastir, Laboratoire de Biochimie, Unité de recherche UR 12ES08 "Signalisation Cellulaire et Pathologies", 5019, Monastir, Tunisie. · Département d'Oncogénétique, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 26392359
  • 1] Clermont Université - Université d'Auvergne - ERTICa - EA 4677 - Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, B.P. 86 - 63172 AUBIERE CEDEX, France [2] Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Centre Jean Perrin, 58 Rue Montalembert, BP 392 - 63011 CLERMONT-FERRAND CEDEX France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677 - Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, B.P. 86 - 63172 AUBIERE CEDEX, France. · UMR 990 INSERM - Université d'Auvergne, BP 184, 63005 CLERMONT-FERRAND CEDEX, France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Faculté de médecine, 28 place Henri Dunant, BP 38 - 63001 Clermont-Ferrand, France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Centre Jean Perrin, 58 Rue Montalembert, BP 392 - 63011 CLERMONT-FERRAND CEDEX France. · Pubmed 26234720
  • Département d'oncologie médicale, Institut Paoli-Calmettes, Marseille, France; Centre de recherche en cancérologie de Marseille, Inserm U1068, CNRS U7258, Aix-Marseille Université, France. Electronic address: · Département de pathologie et de biopathologie, Centre Jean-Perrin, 63011 Clermont-Ferrand cedex, France; EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 26118865
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Pathology and CRB Ferdinand Cabanne, Centre Georges Francois Leclerc, 21000, Dijon, France. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, 31059, Toulouse, France. · Department of Pathology, Centre Jean Perrin, and University of Auvergne, 63000, Clermont Ferrand, France. · Department of Pathology, Centre Oscar Lambret, 59000, Lille, France. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Medical Oncology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Affiliate Member, Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 25994018
  • Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · The Emmes Corporation, Rockville, Maryland, USA. · Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. · Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA. · Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · PhenoPath Laboratories, Seattle, Washington, USA. · Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA. · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada. · Department of Pathology, Kawasaki Medical School, Kurashiki City, Japan. · Department of Pathology, Hakuaikai Sagara Hospital, Matsubaracho, Kagoshima, Japan. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan. · Institut Jules Bordet, Brussels, Belgium. · Birmingham Heart of England, National Health Service, Birmingham, UK. · Slagelse Hospital, Slagelse, Region Sjælland, Denmark. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy. · Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. · Pubmed 25698062
2014
  • Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. Electronic address: · Department of Medical Oncology, Pitié-Salpetriere Hospital, Paris, France. · Department of Oncology and Radiotherapy CRLC Val d'Aurelle, Montpellier, France. · Department of Oncology, Beaujon-Bichat Inter-Hospital, Clichy, France. · Department of Pathology, Jean Perrin Center and EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · Pubmed 24462377
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Institute of Pathology Nordhessen, Kassel, Germany. · Healthscope Pathology, Norwest Private Hospital, Bella Vista, NSW, Australia. · State of São Paulo Cancer Institute (ICESP), São Paulo, Brazil. · Royal Marsden Hospital, London, UK. · International University of Health and Welfare (IUHW), Center for Diagnostic Pathology, IUHW Mita Hospital, Tokyo, Japan. · Centre Jean Perrin and University of Auvergne, EA 4233, Clermont-Ferrand, France. · The Academic Medical Center (AMC), The University of Amsterdam, Amsterdam, The Netherlands. · University of Milan and European Institute of Oncology, Milan, Italy. · Pubmed 23807776
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-FerrandDepartments of Medical Oncology, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · Alexis Vautrin Comprehensive Cancer Centre, Nancy. · Tenon University Hospital, Paris. · Montluçon Hospital Centre, Montluçon. · Leon Berard Comprehensive Cancer Centre, Lyon. · Oscar Lambret Comprehensive Cancer Centre, Lille. · Paul Strauss Comprehensive Cancer Centre, Strasbourg. · Georges François Leclerc Comprehensive Cancer Centre, Dijon. · Departments of Medical Oncology, Clermont-Ferrand. · Jean Godinot Comprehensive Cancer Institute, Reims. · Limoges University Hospital, Limoges. · Departments of Medical Oncology, Clermont-Ferrand Oncauvergne Regional Oncology Network. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand Inserm UMR 990, Clermont-Ferrand University of Auvergne, Clermont-Ferrand, France. · Pubmed 24827135
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Jean Perrin Comprehensive Cancer Center and ERTICA EA4677 Research Team, University of Auvergne, Clermont-Ferrand, France. · Laboratoire de biochimie médicale, Centre de biologie, CHU de Clermont-Ferrand, Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Center and ERTICA EA4677 Research Team, University of Auvergne, Clermont-Ferrand, France; INRA, UMR 1019, UNH, Clermont-Ferrand, France. · Pubmed 25010005
2013
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM) · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON) · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV) · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ) · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L) · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB) · PhenoPath Laboratories, Seattle, WA (AMG) · Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS) · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP) · The EMMES Corporation, Rockville, MD (RAE) · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH) · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD) · on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
  • Centre Jean Perrin, 58 Rue Montalembert, BP 392, 63011 Clermont-Ferrand cédex, France; Université d'Auvergne, EA 4677, 63000 Clermont-Ferrand, France. Electronic address: · Sírio Libanês Hospital, Rua Dona Adma Jafet, 91 - Bela Vista, Sao Paulo, Brazil. Electronic address: · Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room E4 32, Toronto, ON, M4N 3M5, Canada. Electronic address: · Center for Diagnostic Pathology, International University of Health and Welfare (IUHW) Mita Hospital, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan. Electronic address: · Pathology Nordhessen, Germaniastraße 7, 34119 Kassel, Germany. Electronic address: · Divisione di Anatomia Patologica, Istituto Europeo di Oncologia ed Università di Milano, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: · Pubmed 23352656
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
  • ERTICA EA 4677, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 28171863
2015
  • APHP Tenon, IUC-UPMC, Sorbonne Université, Alliance Pour la Recherche en Cancérologie, Paris, France; University Hospital Jean Minjoz, UMR1098, SFR IBCT, Besançon, France; Institut du Cancer Montpellier, Université Montpellier 1, Montpellier, France; Centre Azuréen de Cancérologie, Mougins, France; Centre d'Oncologie de Gentilly, Nancy, France; APHP-St. Louis, Université Paris Diderot, Paris, France; Centre Jean-Perrin, Université d'Auvergne, Clermont-Ferrand, France; Research Unit EA 7285, University of Versailles St-Quentin, Montigny-le-Bretonneux, France; Department of Surgery, Institut Curie, Saint-Cloud, France · APHP Tenon, IUC-UPMC, Sorbonne Université, Alliance Pour la Recherche en Cancérologie, Paris, France; University Hospital Jean Minjoz, UMR1098, SFR IBCT, Besançon, France; Institut du Cancer Montpellier, Université Montpellier 1, Montpellier, France; Centre Azuréen de Cancérologie, Mougins, France; Centre d'Oncologie de Gentilly, Nancy, France; APHP-St. Louis, Université Paris Diderot, Paris, France; Centre Jean-Perrin, Université d'Auvergne, Clermont-Ferrand, France; Research Unit EA 7285, University of Versailles St-Quentin, Montigny-le-Bretonneux, France; Department of Surgery, Institut Curie, Saint-Cloud, France. · Pubmed 26112003
2010
  • Faculté de Pharmacie, Laboratoire SVFp, 28 place Henri-Dunant, B.P. 38, 63000 Clermont-Ferrand, France. · Pubmed 20683033
Probable:    INSERM France      
2018
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, University Clermont Auvergne, 58 rue Montalembert-BP184, 63005 Clermont-Ferrand, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 30324811
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · Master Program « Biology & Health », University Paris-East Val-de-Marne (UPEC), 61 avenue du General de Gaulle, 94010, Creteil, France. · Present Address: Department of Pathology, Paoli-Calmettes Comprehensive Cancer Centre, 232 boulevard Sainte-Marguerite, 13009, Marseilles, France. · Department of Clinical Research, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 29394917
2017
  • Catholic University of the Sacred Heart and A. Gemelli Teaching Hospital Foundation, Rome, Italy. · AstraZeneca, Alderley Park, Macclesfield, UK. · Fundación Instituto Valenciano de Oncología, València, Spain. · Departement de Pathologie, Centre Jean Perrin; INSERM UMR 1240, Clermont-Ferrand, France. · Radboud University Medical Center, Nijmegen, Netherlands. · The Royal Marsden NHS Foundation Trust, London, UK. · Medical University of Vienna, Vienna, Austria. · Sheba Medical Center, Tel Hashomer, Israel. · University of Cologne, Cologne, Germany. · University Hospital Heidelberg, Germany. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Claude Bernard University, Lyon, France. · Princess Margaret Cancer Centre, Toronto, Canada. · Nazionale Tumori IRCCS Pascale, Naples, Italy. · Kantonsspital Aarau, Aarau, Switzerland. · University of Singapore, Singapore. · Queen's University Belfast, Belfast, UK. Electronic address: · Pubmed 29248130
  • Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address: · Centre Jean-Perrin, département de chirurgie oncologique, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France; Université d'Auvergne, faculté de médecine, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France. · Pubmed 27986267
  • Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. · Department of Pharmacogenomics, Institut Curie, Paris, France. · Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · Department of Gynecology, Poissy-St Germain hospital, Poissy, France. · Department of Gynecology, Tenon Hospital, Paris, France. · Department of Gynecology, René Dubos Hospital, Pontoise, France. · Department of Medical Oncology, Private Hospital Clairval, Marseille, France. · Department of Surgery, Private Hospital Les Peupliers, Paris, France. · Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. · NanoString Technologies, Inc., Seattle, WA, United States of America. · Cedar Associates LLC, Menlo Park, CA, United States of America. · Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. · Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. · Pubmed 29045452
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, 58 rue Montalembert-BP184, 63005, Clermont-Ferrand, France. · Department of Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. · University Blaise Pascal, Institute Pascal UMR 6602 CNRS/UBP, 63178, Aubiere, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, 58 rue Montalembert-BP184, 63005, Clermont-Ferrand, France. · Pubmed 28747748
  • Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France. · Pubmed 28065411
  • 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France . · 2 INSERM U 1240, IMOST, Clermont-Ferrand, France . · 3 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France . · Pubmed 28873018
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2013
  • INSERM-UPMC Université Paris 06, UMRS 938, Hôpital Saint-Antoine, 75012, Paris, France. · Pubmed 24166279
  • Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes IPC, 13273 Marseille, France. · Pubmed 23117074
2012
  • INSERM, Centre d'Investigations Cliniques-9501, CHU Nancy & Nancy-Université, 54511 Vandoeuvre-les-Nancy, France. · Pubmed 22048814
2011
  • Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, 232, Bd Ste-Marguerite, Marseille, 13009, France. · Pubmed 22044691
Probable:    Miscellaneous institutions in Clermont-Ferrand      
2018
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, University Clermont Auvergne, 58 rue Montalembert-BP184, 63005 Clermont-Ferrand, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 30324811
  • Institut Curie, Paris Sciences Lettres Research University, Pôle de médecine diagnostique et théranostique, Paris, France. · Institut Curie, Versailles Saint Quentin University, Pôle de médecine diagnostique et théranostique, Saint-Cloud, France. · Department of Pathology, Centre François Baclesse, Caen, France. · Department of Pathology, Centre Léon-Bérard, Lyon, France. · Department of Pathology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France. · Institut Curie, Versailles Saint Quentin University, Surgery Department, Saint-Cloud, France. · Department of Medical Sciences, University of Turin, Turin, Italy. · Pubmed 29537649
  • Institute of Pathology, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. · Département de Pathologie, Centre Jean-Perrin, 58, rue Montalembert, 392, 63011, Clermont-Ferrand cedex 1, BP, France. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Institute of Pathology, University Hospital Dresden, Fetscherstr, 74, 01307, Dresden, Germany. · Institute of Pathology Nordhessen, Germaniastraße 7, 34119, Kassel, Germany. · Institute of Pathology, University Hospital Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. · Targos Molecular Pathology GmbH, Germaniastraße 7, 34119, Kassel, Germany. · Pubmed 29530054
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · Master Program « Biology & Health », University Paris-East Val-de-Marne (UPEC), 61 avenue du General de Gaulle, 94010, Creteil, France. · Present Address: Department of Pathology, Paoli-Calmettes Comprehensive Cancer Centre, 232 boulevard Sainte-Marguerite, 13009, Marseilles, France. · Department of Clinical Research, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 29394917
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, 58 rue Montalembert-BP184, 63005, Clermont-Ferrand, France. · Department of Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. · University Blaise Pascal, Institute Pascal UMR 6602 CNRS/UBP, 63178, Aubiere, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, 58 rue Montalembert-BP184, 63005, Clermont-Ferrand, France. · Pubmed 28747748
  • Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · Private Group Practice for Pathology and PathoPlan GbR, Lübeck, Germany. · Department of Pathology and Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China. · Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany. · Centre Jean Perrin, Centre regional de Lutte contre le cancer d'Auvergne, Clermont-Ferrand, France. · European Institute of Oncology, University of Milan, Milan, Italy. · Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. · Institute of Pathology, Klinikum Region Hannover, Hannover, Germany. · BioNTech Diagnostics GmbH, Mainz, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · ACOMED Statistik, Leipzig, Germany. · Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Transformative Pathology, Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada. · Pubmed 28490348
  • Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand, France. · Université d'Auvergne, ERTICa-EA4677, Faculté de Médecine, 28 place Henri Dunant, Clermont-Ferrand, France. · Adelbio, 13 Rue du Pariou, Aubière, France. · Pubmed 28430808
  • Centre Jean Perrin-ERTICa-EA4677, Clermont-Ferrand Cedex, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Faculté de Médecine, Clermont-Ferrand, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, Aubière cedex, France. · Centre de Ressources Biologiques BB-0033-00075, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 27864890
  • Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse (UICT)-Oncopole, Department of Medical Oncology and Inserm UMR 1037, Team "Cholesterol Metabolism and Therapeutic Innovations", Cancer Research Center, Toulouse, France. · Department of Pathology, Jean Perrin Institute, Clermont Ferrand, France. · Department of Surgery, Private Institute, Aubagne, France. · Department of Surgery, Paoli-Calmettes Institute, Marseille, France. · Breast Institute of Orangerie, Strasbourg, France. · Department of Breast and Gynecologic Surgery, Union Clinic, Saint Jean, France. · Department of Radiotherapy, Roanne Hospital, Roanne, France. · Department of Radiotherapy, Marie Curie Institute, Valence, France. · Roche, France. · Department of Breast Surgery, Oscar Lambret Anti-Cancer Center-UNICANCER, Lille, France. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, and University of Pierre et Marie Curie (UPMC), Paris. · Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address: · Pubmed 27856201
  • 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France . · 2 INSERM U 1240, IMOST, Clermont-Ferrand, France . · 3 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France . · Pubmed 28873018
2016
  • Department of Pathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011 Clermont-Ferrand, France. · ERTICa Research Group, EA4677 University of Auvergne, 49 Boulevard Francois Mitterrand, 63000 Clermont-Ferrand, France. · Pubmed 26856744
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
  • Centre Jean Perrin - ERTICa-EA4677, BP392, 63011 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Faculté de Médecine, BP38, 63001 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble Universitaire des Cézeaux, BP86, 63172 Aubière Cedex, France. · Pubmed 27655662
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France. · EA 4677 'ERTICA', University of Auvergne, 63011 Clermont-Ferrand, France. · Department of Toxicology, Faculty of Pharmacy, Marmara University, 34668 Istanbul, Turkey. · University Blaise Pascal, Pascal Institute UMR 6602 CNRS/UBP, 63177 Aubière, France. · Department of Biopathology, Centre Jean Perrin, 63011 Clermont-Ferrand, France. · Pubmed 27424567
  • a Department of Medical Oncology , Georges François Leclerc Center , Dijon , France. · b Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy , Dijon , France. · c Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif , France. · d Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France. · f INSERM, U1138 , Paris , France. · g Université Paris Descartes, Sorbonne Paris Cité , Paris , France. · h University of Paris Sud XI , Villejuif , France. · i Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · j Center Jean Perrin, EA 4677 Clermont-Ferrand , Clermont-Ferrand , France. · k ERTICa, EA 4677 University of Auvergne , Clermont-Ferrand , France. · l Department of Pathology and Tumor Biology , Georges François Leclerc Center , Dijon , France. · m Biostatistics and Epidemiology Unit, EA 4184, Centre Georges Francois Leclerc Dijon , France. · n Department of Medical Oncology and Breast Cancer Group , Institut Gustave Roussy , Villejuif , France. · o INSERM U981 Identification of molecular predictors and new targets for cancer treatment , Institut Gustave Roussy , Villejuif , France. · p Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris , Paris , France. · q Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital , Stockholm , Sweden. · Pubmed 26979828
  • 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France . · 2 EA 4677 "ERTICA, " University of Auvergne , Clermont-Ferrand, France . · 3 Department of Toxicology, Faculty of Pharmacy, Marmara University , Istanbul, Turkey . · 4 University Blaise Pascal , Pascal Institute UMR 6602 CNRS/UBP, Aubière, France . · 5 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France . · Pubmed 27326890
2015
  • Department of Surgery, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France. · Department of Surgery, Centre Oscar Lambret, Lille, France. · Department of Pathology, Centre Oscar Lambret, Lille, France. · Department of Surgery, Centre Henri Becquerel, Rouen, France. · Department of Pathology, Centre Henri Becquerel, Rouen, France. · Department of Surgery, Centre Jean Perrin, Clermont-Ferrand Cedex 1, France. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex 1, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Surgery, Centre Eugène Marquis, Rennes, France. · Department of Surgery, Centre Hospitalier Universitaire de Limoges, Limoges, France. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · University of Bordeaux, Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France. · INSERM U897, CIC-EC07, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France. · Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France. · Pubmed 25777085
  • Centre Jean Perrin, Clermont-Ferrand, France; Clinical Investigation Center (CIC), Clermont-Ferrand, France; · Centre Jean Perrin, Clermont-Ferrand, France; · Institut Jean-Godinot, Reims, France; · Centre Jean Perrin, Clermont-Ferrand, France; ERTICA EA 4677, Research Team for Individualized Cancer Treatment, and. · UMR 990 INSERM, University of Auvergne, Clermont-Ferrand, France. · Pubmed 25637380
  • a Department of Medical Oncology, Georges François Leclerc Center ; Dijon , France. · b Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy , Villejuif , France. · c Centre Jean Perrin, EA 4677 Clermont-Ferrand ; Clermont-Ferrand , France. · d ERTICa; EA 4677 University of Auvergne ; Clermont-Ferrand , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris , France. · f Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus ; Villejuif , France. · g Biostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon , France. · h Université Paris Descartes; Sorbonne Paris Cité ; Paris , France. · i Department of Pathology and Tumor Biology; Georges François Leclerc Center ; Dijon , France. · j Institut National de la Santé et de la Recherche Médicale; Avenir Team INSERM; CRI-866 University of Burgundy , Dijon , France. · k Department of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy , Villejuif , France. · l INSERM U981 "Identification of molecular predictors and new targets for cancer treatment"; Institut Gustave Roussy ; Villejuif , France. · m University of Paris Sud XI , Villejuif , France. · n Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · o Pôle de Biologie; Hôpital Européen Georges Pompidou; Assistance Publique-Hôpitaux de Paris ; Paris , France. · p INSERM; U1138 , Paris , France. · Pubmed 26506894
  • Institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. · Institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address: · Département chirurgie oncologique, institut de cancérologie de l'Ouest, site René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain cedex, France. · Breast Unit-Surgery-Gustave Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Département de cancérologie sénologique, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France. · IUCT Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · 35, rue Dailly, 92210 Saint-Cloud, France. · Centre Léon-Berard, 28, rue Laennec, 69008 Lyon, France. · Hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. · Centre Georges-François-Leclerc, 1, rue Professeur-Marion, BP 7780, 21079 Dijon cedex, France. · Centre hospitalier de Grasse, chemin de Clavary, BP 53149, 06135 Grasse cedex, France. · Groupe hospitalier Diaconesses-Croix-Saint-Simon, site Reuilly, 18, rue du Sergent-Bauchat, 75012 Paris, France. · Centre Jean-Perrin, 58, rue Montalembert, BP 392, 63011 Clermont-Ferrand cedex 01, France. · Institut Bergonié, 229, cours de l'Argonne, CS 61283, 33076 Bordeaux cedex, France. · Institut de cancérologie de l'Ouest, site René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain cedex, France. · Centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France. · Pubmed 26482833
  • Clermont Université, Université d'Auvergne, UMR 1019, Unité de Nutrition Humaine, CRNH-Auvergne, BP 10448, F-63000, Clermont-Ferrand, France; Oxidative Stress and Inflammation, Department of Public Health and Caring Sciences, Faculty of Medicine, Uppsala University, Uppsala, Sweden. · Clermont Université, Université d'Auvergne, UMR 1019, Unité de Nutrition Humaine, CRNH-Auvergne, BP 10448, F-63000, Clermont-Ferrand, France. · Centre Jean Perrin, Unicancer, F-63000, Clermont-Ferrand, France. · Clermont Université, Université d'Auvergne, UMR 1019, Unité de Nutrition Humaine, CRNH-Auvergne, BP 10448, F-63000, Clermont-Ferrand, France; Centre Jean Perrin, Unicancer, F-63000, Clermont-Ferrand, France; CHU Clermont-Ferrand, Unité d'exploration nutritionnelle, F-63003, Clermont-Ferrand, France. · Pubmed 26431176
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Institut Paoli Calmettes and CRCM, 232 Bd Sainte Marguerite, Marseille, France; Aix Marseille Université, France. Electronic address: · Institut René Gauducheau, Site hospitalier Nord, St Herblain, France. · Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France. · Centre Oscar Lambret, 3 rue Frédéric Combenal, Lille, France. · Institut Paoli Calmettes and CRCM, 232 Bd Sainte Marguerite, Marseille, France. · Centre Léon Bérard, 28 rue Laennec, Lyon, France. · Centre Claudius Regaud, 20-24 rue du Pont St Pierre, Toulouse, France. · Centre René Huguenin, 35 rue Dailly, Saint Cloud, France. · Hôpital Tenon, 4 rue de la Chine, Paris, France. · Centre Georges François Leclerc, 1 rue du Professeur Marion, Dijon, France. · Hôpital de Grasse, Chemin de Clavary, Grasse, France. · Hôpital des Diaconnesses, 18 rue du Sergent Bauchat, Paris, France. · Centre Jean Perrin, 58 rue Montalembert, Clermont Ferrand, France. · Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, France. · Institut Paoli Calmettes and CRCM, 232 Bd Sainte Marguerite, Marseille, France; Aix Marseille Université, France. · Biostatistic, France. · Pubmed 24874284
2013
  • Département de pathologie et de biopathologie, centre Jean-Perrin, 63011 Clermont-Ferrand Cedex, France. · Département de pathologie et de biopathologie, centre Jean-Perrin, 63011 Clermont-Ferrand Cedex, France. · Pubmed 24579333
2012
  • Department of Pathology, Centre Jean-Perrin, Clermont-Ferrand, France. · Pubmed 23012297
2011
  • Centre Jean-Perrin, service de pathologie, 58, rue Montalembert BP 392, 63011 Clermont-Ferrand, France. · Pubmed 21727059
2010
  • Centre Jean-Perrin, département de pathologie, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Pubmed 21055523
  • Service d'anatomopathologie, Centre Jean-Perrin, 58, rue Montalembert, BP 392, 63011 Clermont-Ferrand Cedex, France. · Pubmed 21163733
2014
  • Department of Oncogenetics, Centre Jean Perrin-CBRV, 63000 Clermont-Ferrand, France. · Pubmed 25531258
2011
  • Department of Oncogenetic, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 21966417
  • Département de chirurgie, centre Jean-Perrin, Clermont-Ferrand, France. · Pubmed 21349382
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 100 total) written by Frederique M. Penault-Llorca about Breast Neoplasms:

  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. 2018
  • TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer. 2018
  • The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial). 2018
  • High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast. 2018
  • Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer. 2018
  • Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients. 2017
  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. 2017
Show List of Full Article Records
Google Searches

Learn more about Frederique M. Penault-Llorca using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite Clermont Auvergne
INSERM France
Miscellaneous institutions in Clermont-Ferrand
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite Clermont Auvergne
2018
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri-Dunant, 63001, Clermont-Ferrand, France. · INSERM U 1240, IMOST, University Clermont Auvergne, 58 rue Montalembert-BP184, 63005 Clermont-Ferrand, France. · Department of Biopathology, Centre Jean Perrin, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 30324811
  • Department of Biopathology, Centre Jean Perrin and EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000, Clermont-Ferrand, France. · Department of Biostatistics, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Institut Curie, Paris, France. · Genomic Health Inc, Redwood City, CA, USA. · University of California, San Francisco, CA, USA. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. · Department of Pathology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Department of Biostatistics, Centre Val d'Aurelle, Montpellier, France. · Department of Pathology, Institut de Cancérologie de l'Ouest (site René Gauducheau), Nantes, Saint-Herblain, France. · Unicancer, Paris, France. · Department of Medical Oncology, Institut Claudius Régaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France. · Pubmed 29728098
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · Master Program « Biology & Health », University Paris-East Val-de-Marne (UPEC), 61 avenue du General de Gaulle, 94010, Creteil, France. · Present Address: Department of Pathology, Paoli-Calmettes Comprehensive Cancer Centre, 232 boulevard Sainte-Marguerite, 13009, Marseilles, France. · Department of Clinical Research, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France. · University Clermont Auvergne, INSERM U1240, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Pubmed 29394917
2017
  • Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address: · Centre Jean-Perrin, département de chirurgie oncologique, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France; Université d'Auvergne, faculté de médecine, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France. · Pubmed 27986267
  • Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. · Department of Pharmacogenomics, Institut Curie, Paris, France. · Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · Department of Gynecology, Poissy-St Germain hospital, Poissy, France. · Department of Gynecology, Tenon Hospital, Paris, France. · Department of Gynecology, René Dubos Hospital, Pontoise, France. · Department of Medical Oncology, Private Hospital Clairval, Marseille, France. · Department of Surgery, Private Hospital Les Peupliers, Paris, France. · Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. · NanoString Technologies, Inc., Seattle, WA, United States of America. · Cedar Associates LLC, Menlo Park, CA, United States of America. · Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. · Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. · Pubmed 29045452
  • Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand, France. · Université d'Auvergne, ERTICa-EA4677, Faculté de Médecine, 28 place Henri Dunant, Clermont-Ferrand, France. · Adelbio, 13 Rue du Pariou, Aubière, France. · Pubmed 28430808
  • Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France. · LabEx DEVweCAN, Université de Lyon, Lyon, France. · Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France. · Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France. · Centre Léon Bérard, Lyon, France. · Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · ProfileXpert, Bron, France. · Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Clinique Phenicia, Marseille, France. · Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. · Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28394329
  • Departement of oncogenetics, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, University of Auvergne, Clermont-Ferrand, France. · Laboratory of Biochemistry Research unit UR 12ES08 Cell Signaling and Disease, Faculty of Medicine of Monastir, University of Monastir, 5019, Monastir, Tunisia. · Department of Pathology, Farhat Hached Hospital, 4000, Sousse, Tunisia. · Laboratory of Biochemistry Research unit UR 12ES08 Cell Signaling and Disease, Faculty of Medicine of Monastir, University of Monastir, 5019, Monastir, Tunisia. · Pubmed 28101798
  • Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France. · Pubmed 28065411
  • Centre Jean Perrin-ERTICa-EA4677, Clermont-Ferrand Cedex, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Faculté de Médecine, Clermont-Ferrand, France. · Clermont Université-Université d'Auvergne-ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, Aubière cedex, France. · Centre de Ressources Biologiques BB-0033-00075, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 27864890
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France; EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France; EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France. Electronic address: · EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France; Department of Pathology, Centre Jean Perrin, 63011, Clermont-Ferrand, France. · Pubmed 26965997
  • Department of Pathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011 Clermont-Ferrand, France. · ERTICa Research Group, EA4677 University of Auvergne, 49 Boulevard Francois Mitterrand, 63000 Clermont-Ferrand, France. · Pubmed 26856744
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
  • Centre Jean Perrin - ERTICa-EA4677, BP392, 63011 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Faculté de Médecine, BP38, 63001 Clermont-Ferrand Cedex, France. · Clermont Université - Université d'Auvergne - ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble Universitaire des Cézeaux, BP86, 63172 Aubière Cedex, France. · Pubmed 27655662
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France. · EA 4677 'ERTICA', University of Auvergne, 63011 Clermont-Ferrand, France. · Department of Toxicology, Faculty of Pharmacy, Marmara University, 34668 Istanbul, Turkey. · University Blaise Pascal, Pascal Institute UMR 6602 CNRS/UBP, 63177 Aubière, France. · Department of Biopathology, Centre Jean Perrin, 63011 Clermont-Ferrand, France. · Pubmed 27424567
  • Synergie Lyon Cancer, Plateforme de bioinformatique 'Gilles Thomas' Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Institut Curie, PSL Research University, Département de Pathologie, INSERM U934, 26 rue d'Ulm, 75248 Paris, France. · Centre Hospitalier Universitaire de Minjoz, UMR INSERM 1098, Boulevard A. Fleming, Besançon 25000, France. · Plateforme de génomique des cancers, Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Institut Curie, UMR 3215 CNRS, Génétique et biologie du développement, Epigénèse et développement des mammifères, U934 Inserm, 26 rue d'Ulm, 75248 Paris, France. · Centre Léon Bérard, Département de Pathologie, 28 rue Laënnec, 69008 Lyon, France. · Département de Biopathologie, Unité Inserm U916, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France. · Centre Georges-François Leclerc et CRB Ferdinand Cabanne, 1 rue du Professeur Marion, Inserm U866-UBFC, 21000 Dijon, France. · Centre d'Etude du Polymorphisme Humain (CEPH), Fondation Jean Dausset, 27 rue Juliette Dodu, 75010 Paris, France. · Institut Paoli-Calmettes, Département de Pathologie, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Institut Gustave Roussy, Comité de Pathologie Mammaire, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Centre Jean Perrin, Département de Biopathologie, EA 4677 ERTICa, Université d'Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France. · Institut Régional du Cancer de Montpellier (ICM), Département de Pathologie, 208 Avenue des Apothicaires, 34298 Montpellier, France. · Institut Curie, PSL Research University, Service de Pathologie, Centre de Ressources Biologiques, BRIF BB-0033-00048, 26 rue d'Ulm, 75248 Paris, France. · Département de Pathologie, Institut Bergonié, 229 cours de l'Argonne, CS 61283, 33076 Bordeaux, France. · Institut Curie, PSL Research University, Département d'Oncologie Médicale, Université Paris Descartes, 26 rue d'Ulm, 75248 Paris, France. · Centre Léon Bérard, Département de Cancérologie Médicale, 28 rue Laënnec, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié Unicancer, University of Bordeaux, INSERM U916, CIC1401, 229 cours de l'Argonne, CS 61283, 33076 Bordeaux, France. · Institut Régional du Cancer de Montpellier (ICM), Oncologie Sénologie, 208 Avenue des Apothicaires, 34298 Montpellier, France. · Centre Alexis Vautrin, Département d'Oncologie Médicale, 6 Avenue de Bourgogne, 54511 Vandoeuvre Les Nancy, France. · Centre Antoine Lacassagne, Département d'Oncologie Médicale, 33 Avenue de Valombrose, 06189 Nice, France. · Institut Paoli-Calmettes, Département d'Oncologie Médicale, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Clinique Mutualiste de Bellevue, Chirurgie Gynécologique et Mammaire, 3 rue le Verrier, 42100 Saint-Etienne, France. · Institut Gustave Roussy, Cancer Core Europe, 39 rue Camille Desmoulins, Villejuif 94805, France. · CNAG-CRG, Centre for Genomic Regulation (CRG), C/Baldiri Reixac 4, 08028 Barcelona, Spain. · Universitat Pompeu Fabra, Plaça de la Mercè, 10, 08002 Barcelona, Spain. · Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Institut National du Cancer, Département de Recherche Clinique, 52 Avenue Morizet, 92513 Boulogne-Billancourt, France. · INSERM U1052-CNRS 5286, Cancer Research Center of Lyon, F-69008 Lyon, France. · Université de Lyon, F-69622 Lyon, France. · Centre Léon Bérard, 28 rue Laënnec, 69008 Lyon, France. · Département d'Oncologie Moléculaire, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Aix-Marseille Université, 232 boulevard de Sainte-Marguerite, 13009 Marseille, France. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655 Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Pubmed 27406316
  • Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France. · University Blaise Pascal, Institute Pascal UMR 6602 CNRS/UBP, Aubière, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France Department of Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. · EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France · Pubmed 27365379
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • a Department of Medical Oncology , Georges François Leclerc Center , Dijon , France. · b Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy , Dijon , France. · c Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif , France. · d Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France. · f INSERM, U1138 , Paris , France. · g Université Paris Descartes, Sorbonne Paris Cité , Paris , France. · h University of Paris Sud XI , Villejuif , France. · i Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · j Center Jean Perrin, EA 4677 Clermont-Ferrand , Clermont-Ferrand , France. · k ERTICa, EA 4677 University of Auvergne , Clermont-Ferrand , France. · l Department of Pathology and Tumor Biology , Georges François Leclerc Center , Dijon , France. · m Biostatistics and Epidemiology Unit, EA 4184, Centre Georges Francois Leclerc Dijon , France. · n Department of Medical Oncology and Breast Cancer Group , Institut Gustave Roussy , Villejuif , France. · o INSERM U981 Identification of molecular predictors and new targets for cancer treatment , Institut Gustave Roussy , Villejuif , France. · p Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris , Paris , France. · q Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital , Stockholm , Sweden. · Pubmed 26979828
  • Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif University Paris-Sud, University Paris-Saclay, UVSQ, CESP, INSERM, Villejuif Plateform Ligue nationale contre le cancer for meta-analyses in oncology, Gustave Roussy, Villejuif, France Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Institut Jules Bordet, Université Libre de Bruxelles, Brussels Breast International Group (BIG), Brussels, Belgium. · Unit of Biostatistics and Epidemiology, Gustave Roussy, Villejuif. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. · Department of Oncology, University of Edinburgh, Edinburgh, UK. · Rush University Medical Center, Chicago, USA. · Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Unit, Royal Marsden Hospital, London, UK. · Scientific Direction, IRCCS National Cancer Research Centre "Giovanni Paolo II," Bari, Italy. · The Institute of Breast Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Breast Cancer Diseases Unit and Department of Medical Oncology, Saint Louis Hospital, APHP, Paris, France. · German Breast Group, GBG ForschungsGmbH, Neu-Isenburg, Germany. · Department of Pathology, Centre Jean Perrin, EA 4233, University of Auvergne, Clermont-Ferrand, France. · Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles. · University of Miami School of Medicine, Comprehensive Cancer Research Group Inc, Columbia Cancer Research Network of Florida, Miami, USA. · IDDI, Louvain-la-Neuve, Hasselt University, Hasselt, Belgium. · Pubmed 26961151
  • 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France . · 2 EA 4677 "ERTICA, " University of Auvergne , Clermont-Ferrand, France . · 3 Department of Toxicology, Faculty of Pharmacy, Marmara University , Istanbul, Turkey . · 4 University Blaise Pascal , Pascal Institute UMR 6602 CNRS/UBP, Aubière, France . · 5 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France . · Pubmed 27326890
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France; CREAT EA 7283, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. Electronic address: · Pubmed 25900915
  • Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Europa Donna Cyprus, Nicosia, Cyprus. · Breast Oncology Center, Cancer Institute Hospital, Tokyo, Japan. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Diagnostic Radiology, Lund University, Malmö, Sweden. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Pubmed 26314782
  • a Department of Medical Oncology, Georges François Leclerc Center ; Dijon , France. · b Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy , Villejuif , France. · c Centre Jean Perrin, EA 4677 Clermont-Ferrand ; Clermont-Ferrand , France. · d ERTICa; EA 4677 University of Auvergne ; Clermont-Ferrand , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris , France. · f Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus ; Villejuif , France. · g Biostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon , France. · h Université Paris Descartes; Sorbonne Paris Cité ; Paris , France. · i Department of Pathology and Tumor Biology; Georges François Leclerc Center ; Dijon , France. · j Institut National de la Santé et de la Recherche Médicale; Avenir Team INSERM; CRI-866 University of Burgundy , Dijon , France. · k Department of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy , Villejuif , France. · l INSERM U981 "Identification of molecular predictors and new targets for cancer treatment"; Institut Gustave Roussy ; Villejuif , France. · m University of Paris Sud XI , Villejuif , France. · n Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · o Pôle de Biologie; Hôpital Européen Georges Pompidou; Assistance Publique-Hôpitaux de Paris ; Paris , France. · p INSERM; U1138 , Paris , France. · Pubmed 26506894
  • Département d'Oncogénétique, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, Université d'Auvergne, Clermont-Ferrand, France. · Faculté de médecine de Monastir, Laboratoire de Biochimie, Unité de recherche UR 12ES08 "Signalisation Cellulaire et Pathologies", 5019, Monastir, Tunisie. · Département d'Oncogénétique, Centre Jean Perrin, BP 392, 63011, Clermont-Ferrand, France. · EA4677 ERTICA, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 26392359
  • 1] Clermont Université - Université d'Auvergne - ERTICa - EA 4677 - Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, B.P. 86 - 63172 AUBIERE CEDEX, France [2] Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Centre Jean Perrin, 58 Rue Montalembert, BP 392 - 63011 CLERMONT-FERRAND CEDEX France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677 - Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, B.P. 86 - 63172 AUBIERE CEDEX, France. · UMR 990 INSERM - Université d'Auvergne, BP 184, 63005 CLERMONT-FERRAND CEDEX, France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Faculté de médecine, 28 place Henri Dunant, BP 38 - 63001 Clermont-Ferrand, France. · Clermont Université - Université d'Auvergne - ERTICa - EA 4677. Centre Jean Perrin, 58 Rue Montalembert, BP 392 - 63011 CLERMONT-FERRAND CEDEX France. · Pubmed 26234720
  • Département d'oncologie médicale, Institut Paoli-Calmettes, Marseille, France; Centre de recherche en cancérologie de Marseille, Inserm U1068, CNRS U7258, Aix-Marseille Université, France. Electronic address: · Département de pathologie et de biopathologie, Centre Jean-Perrin, 63011 Clermont-Ferrand cedex, France; EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 26118865
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Pathology and CRB Ferdinand Cabanne, Centre Georges Francois Leclerc, 21000, Dijon, France. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Departments of Anatomic Pathology and Oncology, Hospital Israelita Albert Einstein, São Paulo, 05652-900, Brazil. · Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, 31059, Toulouse, France. · Department of Pathology, Centre Jean Perrin, and University of Auvergne, 63000, Clermont Ferrand, France. · Department of Pathology, Centre Oscar Lambret, 59000, Lille, France. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Medical Oncology, Institut Curie, 75248, Paris, France. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Department of Tumor Biology, Institut Curie, 75248, Paris, France. &midd